Aller au contenu principal

 Articles scientifiques

Lurbinectedin as second-line treatment for patients with small-cell lung cancer: a single-arm, open-label, phase 2 basket trial.

Auteurs : Trigo J, Subbiah V, Besse B, Moreno V, López R, Sala MA, Peters S, Ponce S, Fernández C, Alfaro V, Gómez J, Kahatt C, Zeaiter A, Zaman K, Boni V, Arrondeau J, Martínez M, Delord JP, Awada A, Kristeleit R, Olmedo ME, Wannesson L, Valdivia J, Rubio MJ, Anton A, Sarantopoulos J, Chawla SP, Mosquera-Martinez J, DArcangelo M, Santoro A, Villalobos VM, Sands J, Paz-Ares L
Année : 2020
Journal : Lancet Oncol
Volume : 21
Pages : 645-654

Repurposing anticancer drugs for COVID-19-induced inflammation, immune dysfunction, and coagulopathy.

Auteurs : Saini KS, Lanza C, Romano M, de Azambuja E, Cortes J, de Las Heras B, de Castro J, Lamba Saini M, Loibl S, Curigliano G, Twelves C, Leone M, Patnaik MM
Année : 2020
Journal : Br J Cancer

Outcomes based on age in the phase III METEOR trial of cabozantinib versus everolimus in patients with advanced renal cell carcinoma.

Auteurs : Donskov F, Motzer RJ, Voog E, Hovey E, Grüllich C, Nott LM, Cuff K, Gil T, Jensen NV, Chevreau C, Negrier S, Depenbusch R, Bergmann L, Cornelio I, Champsaur A, Escudier B, Pal S, Powles T, Choueiri TK
Année : 2020
Journal : Eur J Cancer
Volume : 126
Pages : 1-10

Lessons learned at SABCS 2019 and to-dos from immunotherapy in breast cancer.

Auteurs : Eiger D, Brandão M, de Azambuja E
Année : 2020
Journal : ESMO Open
Volume : 5

ESR1 mutations and overall survival on fulvestrant versus exemestane in advanced hormone receptor positive breast cancer: A combined analysis of the phase III SoFEA and EFECT trials.

Auteurs : Turner NC, Swift C, Kilburn LS, Fribbens C, Beaney M, Garcia-Murillas I, Buzdar AU, Roberston JF, Gradishar W, Piccart M, Schiavon G, Bliss JM, Dowsett M, Johnston SRD, Chia SK
Année : 2020
Journal : Clin Cancer Res

Personalized selective internal radiation therapy in liver metastasis of thyroid cancer with impaired liver function: A case report.

Auteurs : Herchuelz M, Marin G, Derijckere ID, Vouche M, Delatte P, Donckier V, Liberale G, Hendlisz A, Artigas C, Bourgeois P, Flamen P
Année : 2020
Journal : Radiol Case Rep
Volume : 15
Pages : 548-551

The added value of geriatric assessment in evaluating a patient's Health-Related Quality-of-Life: A study in =70-year-old early-stage invasive breast cancer patients.

Auteurs : Quinten C, Kenis C, Hamaker M, Coolbrandt A, Brouwers B, Dal Lago L, Neven P, Vuylsteke P, Debrock G, Van den Bulck H, Smeets A, Schöffski P, Wedding U, Wildiers H
Année : 2020
Journal : Eur J Cancer Care (Engl)
Pages : e13278

Long-term cardiac outcomes of patients with HER2-positive breast cancer treated in the adjuvant lapatinib and/or trastuzumab Treatment Optimization Trial.

Auteurs : Eiger D, Pondé NF, Agbor-Tarh D, Moreno-Aspitia A, Piccart-Gebhart M, Hilbers FS, Werner O, Chumsri S, Dueck A, Kroep JR, Gomez H, Láng I, Rodeheffer RJ, Ewer MS, Suter T, de Azambuja E
Année : 2020
Journal : Br J Cancer

Use of granulocyte-colony stimulating factors in older patients: a review of recently published data.

Auteurs : Klastersky JA, Dal Lago L, Lalami Y
Année : 2020
Journal : Curr Opin Oncol
Volume : 32
Pages : 258-261

The Legacy of Professor Aron Goldhirsch.

Auteurs : Gelber Rd, Coates AS, Gelber S, Orecchia R, Veronesi P, Di Leo A, Colleoni M, Winer EP, Burstein HJ, Viale G, Senn HJ, Piccart-Gebhart M, Curigliano G
Année : 2020
Journal : Ann Oncol

Editorial: Adjuvant chemotherapy for gastrointestinal cancers: we can do much better.

Auteurs : Sclafani F, Hendlisz A
Année : 2020
Journal : Curr Opin Oncol
Volume : 32
Pages : 344-346

The Impact of Thyroid Disorders on Clinical Pregnancy Outcomes in a Real-World Study Setting.

Auteurs : Sitoris G, Veltri F, Kleynen P, Cogan A, Belhomme J, Rozenberg S, Pepersack T, Poppe K
Année : 2020
Journal : Thyroid
Volume : 30
Pages : 106-115

Metronomic chemotherapy combined with endocrine therapy: are we challenging some dogmas?

Auteurs : Caparica R, de Angelis C, Fêde Â, Werutsky G, de Azambuja E
Année : 2020
Journal : Expert Rev Anticancer Ther
Pages : 1-11

COVID-19 Pneumonia Mimicking Immunotherapy-Induced Pneumonitis on 18F-FDG PET/CT in a Patient Under Treatment With Nivolumab.

Auteurs : Artigas C, Lemort M, Mestrez F, Gil T, Flamen P
Année : 2020
Journal : Clin Nucl Med

Reference values for the EORTC QLQ-C30 in early and metastatic breast cancer.

Auteurs : Mierzynska J, Taye M, Pe M, Coens C, Martinelli F, Pogoda K, Velikova G, Bjelic-Radisic V, Cardoso F, Brain E, Ignatiadis M, Piccart-Gebhart M, Van Tienhoven G, Mansel R, Wildiers H, Bottomley A
Année : 2020
Journal : Eur J Cancer
Volume : 125
Pages : 69-82

HER2-positive advanced breast cancer treatment in 2020.

Auteurs : Cesca MG, Vian L, Cristóvão-Ferreira S, Pondé N, de Azambuja E
Année : 2020
Journal : Cancer Treat Rev
Volume : 88
Pages : 102033

A radical approach to achieve complete cytoreductive surgery improve survival of patients with advanced ovarian cancer.

Auteurs : Liberale G, Pop CF, Polastro L, Kerger J, Moreau M, Chintinne M, Larsimont D, Nogaret JM, Veys I
Année : 2020
Journal : J Visc Surg
Volume : 157
Pages : 79-86

The impact of cyclin-dependent kinase 4 and 6 inhibitors (CDK4/6i) on the incidence of alopecia in patients with metastatic breast cancer (BC).

Auteurs : Eiger D, Wagner M, Pondé NF, Nogueira MS, Buisseret L, de Azambuja E
Année : 2020
Journal : Acta Oncol
Volume : 59
Pages : 723-725

Analysis of inflammatory markers and hormones in old cancer patients: A descriptive study.

Auteurs : De Breucker S, Luce S, Njemini R, Bautmans I, Decoster L, Mets T, Pepersack T
Année : 2020
Journal : Exp Gerontol
Volume : 130
Pages : 110787

Standard Anthracycline Based Versus Docetaxel-Capecitabine in Early High Clinical and/or Genomic Risk Breast Cancer in the EORTC 10041/BIG 3-04 MINDACT Phase III Trial.

Auteurs : Delaloge S, Piccart M, Rutgers E, Litière S, van t Veer LJ, van den Berkmortel F, Brain E, Dudek-Peric A, Gil-Gil M, Gomez P, Hilbers FS, Khalil Z, Knox S, Kuemmel S, Kunz G, Lesur A, Pierga JY, Ravdin P, Rubio IT, Saghatchian M, Smilde TJ, Thompson AM, Viale G, Zoppoli G, Vuylsteke P, Tryfonidis K, Poncet C, Bogaerts J, Cardoso F
Année : 2020
Journal : J Clin Oncol
Volume : 38
Pages : 1186-1197